BMY — Bristol-Myers Squibb Co Share News
0.000.00%
Last trade - 00:00- $110.27bn
- $144.28bn
- $48.19bn
Brief: Mubadala Investment Co Pjsc Reports Share Stake In Pfizer, Abbvie, Dissolves in Merck, Dell
Brief: U.S. FDA Accepts Bristol Myers Squibb's NDA For Iberdomide In Multiple Myeloma
Brief: U.S. Food And Drug Administration Accepts Bristol Myers Squibb's New Drug Application For Iberdomide
Street View: Bristol Myers Squibb drug pipeline in focus as key patent expiry looms
U.S. STOCKS ON THE MOVE-Netflix, FirstCash Holdings, CF Bankshares
Bayer says its experimental blood thinner cuts risk of stroke recurrence by 26%
U.S. STOCKS ON THE MOVE-OneSpaWorld, IMUNON, Cigna
Bristol Myers forecasts upbeat 2026, expecting Eliquis price cut to pay off (updated)
Bristol Myers climbs after forecasting upbeat 2026 profit
Brief: Bristol Myers Expects 2026 Adj EPS $6.05 To $6.35 vs IBES Estimate $6.02
Bristol Myers forecasts upbeat 2026, expecting Eliquis price cut to pay off
UK's Oxford Biomedica rises after multi-year commercial supply deal with BMS
Brief: Oxford BioMedica Signs Multi-Year Supply Agreement With Bristol Myers Squibb
Health Rounds: Cancer immunotherapies may be more effective given earlier in the day
Brief: Bristol Myers Squibb Launches Campaign With Johnson & Johnson
Brief: Opdivo Plus Yervoy Reimbursed Under Ontario's Fast Program As First-Line Treatment For Advanced Liver Cancer
Moderna CMO Jacqueline Miller to step down
Lilly, Repertoire enter up to $1.93 billion deal to develop autoimmune therapies (updated)
U.S. STOCKS ON THE MOVE-Applied Materials, Sherwin-Williams, Caterpillar